Dr. Martens (DOCS): Levers for Growth strategy
This situation live
DOCS Dr. Martens
20 Nov 2025 · Early execution, green shoots reported · −9% until the next step
As we set out in June, we're pivoting from a channel-first to a consumer-first strategy.
27 Jan 2026 · Executing; wholesale and Americas progressing, EMEA DTC weak · −1% until the next step
We are continuing to make good progress with all four Levers for Growth and are on track with our strategic objectives for FY26:
8 Apr 2026 · Executing; market GM structure and Executive Team installed · +0% until the next step
In order to embed and deliver the new strategy, we have made several organisational changes, moving to a market level structure to be closer to the consumer, combined with strengthening Global Brand,
19 May 2026 · Pivot phase done; scale phase starting FY27 · +12% until the next step
There is more work to do in pivoting the business, however in FY27 we will also enter the scale phase of the strategy.
15 Jul 2026 · Scale phase, on track in early FY27 · −12% since
are on track with our strategic objectives for FY27
Levers for Growth strategy
Scale phase, on track in early FY27
Every step · 5
- 20 Nov 2025 Early execution, green shoots reported – As we set out in June, we're pivoting from a channel-first to a consumer-first strategy. ↗
- 27 Jan 2026 Executing; wholesale and Americas progressing, EMEA DTC weak – We are continuing to make good progress with all four Levers for Growth and are on track with our strategic objectives for FY26: ↗
- 8 Apr 2026 Executing; market GM structure and Executive Team installed – In order to embed and deliver the new strategy, we have made several organisational changes, moving to a market level structure to be closer to the... ↗
- 19 May 2026 Pivot phase done; scale phase starting FY27 – There is more work to do in pivoting the business, however in FY27 we will also enter the scale phase of the strategy. ↗
- 15 Jul 2026 Scale phase, on track in early FY27 – are on track with our strategic objectives for FY27 ↗
What is happening
Dr. Martens: Levers for Growth strategy – Scale phase, on track in early FY27. ['Scale phase, on track in early FY27']
- In short
- Levers for Growth strategy: the pivot phase finished and the scale phase began in FY27. The AGM update says the company is on track with its four FY27 objectives. These are full price mix in UK and DACH, a new sandals range, new retail concepts in key cities, and operating model and technology benefits. No figures given.
- Announced
- 20 Nov 2025 · Early execution, green shoots reported
- Latest
- 15 Jul 2026 · Scale phase, on track in early FY27
- FY27 objectives
- Full price mix in UK and DACH; new sandals range; new retail concepts in key cities; operating model and technology benefits
- Progress
- On track with strategic objectives for FY27, per AGM update on 15 July 2026
- Regional trading
- USA growing, wholesale encouraging; Japan and South Korea performing well; Europe as expected
From the company's own announcements. Not investment advice.
Briefing Pro
New to Dr. Martens? Get up to speed in 2 minutes.
What it does, how it got here, what management promised and delivered – written from its own announcements.
Get the DOCS briefing →Also at Dr. Martens 0 open
Insider conviction1 director buying – £156k in 2 buys · closed
Insider conviction2 directors buying – £79k in 2 buys · closed
Insider conviction1 director buying – £18k in 1 buy · closed
Insider conviction3 directors buying – £65k in 3 buys · closed
Dr. Martens – company page →